E, V., F, P., K, R., R, S., N, B., L, O., . . . I, P. (2008). Biochemical assay-based selectivity profiling of clinically relevant kinase inhibitors on mutant forms of EGF receptor. Journal of receptor and signal transduction research, 28(3), 295. https://doi.org/10.1080/10799890802084671
Chicago Style (17th ed.) CitationE, Varkondi, Pinter F, Robert K, Schwab R, Breza N, Orfi L, Keri G, and Petak I. "Biochemical Assay-based Selectivity Profiling of Clinically Relevant Kinase Inhibitors on Mutant Forms of EGF Receptor." Journal of Receptor and Signal Transduction Research 28, no. 3 (2008): 295. https://doi.org/10.1080/10799890802084671 .
MLA (9th ed.) CitationE, Varkondi, et al. "Biochemical Assay-based Selectivity Profiling of Clinically Relevant Kinase Inhibitors on Mutant Forms of EGF Receptor." Journal of Receptor and Signal Transduction Research, vol. 28, no. 3, 2008, p. 295, https://doi.org/10.1080/10799890802084671 .